Michael Melanson receives 10,000 McEwen options; vesting starts Aug 2026

Rhea-AI Filing Summary

McEwen Inc. director Michael Nelson Melanson was granted 10,000 stock options on 08/11/2025 with an exercise (conversion) price of $10.43. The filing reports these options as directly beneficially owned by Mr. Melanson following the grant and shows no cash purchase associated with the grant.

The options vest in three equal annual installments beginning August 11, 2026 and expire on August 11, 2030. The filing is a single-person Form 4 reporting this equity award to a company director; it contains no other transactions, cash exercises, or changes in outstanding common stock reported.

Insights

Securities Analyst

TL;DR: A routine director option grant of 10,000 options at $10.43 with multi-year vesting; notable for alignment, not a material event.

The grant of 10,000 stock options at an exercise price of $10.43 is reported as directly owned by the director. The options vest in three equal annual installments starting 08/11/2026 and expire 08/11/2030. From a securities perspective this is a standard equity-compensation event designed to align management/director incentives with shareholder value over time. The filing shows no disposition or exercise activity tied to this transaction.

Corporate Governance Expert

TL;DR: Time-based vesting ties the director to long-term performance; direct ownership simplifies disclosure and governance tracking.

This Form 4 documents a time-based option award to a director with a clear vesting schedule—three equal annual installments beginning 08/11/2026—which supports retention and alignment objectives. The direct ownership form indicates the director holds the options personally rather than through an indirect vehicle. The disclosure is complete regarding vesting and expiration dates but does not include additional context such as grant rationale or total outstanding option pool size.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Melanson Michael Nelson

(Last) (First) (Middle)

C/O MCEWEN INC.

150 KING STREET WEST, SUITE 2800

(Street)

TORONTO A6 M5H 1J9

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
McEwen Inc. [ MUX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$10.43	08/11/2025		A		10,000		(1)	08/11/2030	Common Stock	10,000	$0	10,000	D

Explanation of Responses:

1. The option vests in three equal annual installments, beginning August 11, 2026.

	/s/ Michael Nelson Melanson	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Michael Nelson Melanson report on the Form 4 for McEwen Inc. (MUX)?

He reported a grant of 10,000 stock options on 08/11/2025 with an exercise price of $10.43, held directly.

When do the options granted to the MUX director vest and expire?

The options vest in three equal annual installments beginning August 11, 2026 and expire on August 11, 2030.

Does the Form 4 show the options were exercised for cash?

No. The filing shows the grant of options and lists the price as the exercise/conversion price $10.43; there is no reported cash exercise associated with this transaction.

What is the reporting relationship of Michael Nelson Melanson to McEwen Inc. (MUX)?

The Form 4 identifies Michael Nelson Melanson as a Director of McEwen Inc.

Was this Form 4 filed by more than one reporting person?

No. The filing indicates it was submitted by one reporting person.